SCHEMBL8874107

SCHEMBL8874107

Cc1cc(C)c2nc(-c3ccccc3)c(=O)[nH]c2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ NPC1 O15118 3/20 0.53
▸ RPS6KA3 P51812 1/20 0.47
▸ DHODH Q02127 3/20 0.45
▸ POLB P06746 1/20 0.44
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44
▸ GRIN2B Q13224 1/20 0.44
▸ GRIN2C Q14957 1/20 0.44
▸ GRIN3A Q8TCU5 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ XDH P47989 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.42
▸ PARP1 P09874 2/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ BRD4 O60885 1/20 0.41
▸ CHEK1 O14757 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14844694 0.82 KDM4E (0.59) RAB9AKDM4ENPC1POLBPARP1
SCHEMBL28872962 0.78 RPS6KA3 (0.72) RPS6KA3DHODHESR1
SCHEMBL29899918 0.78 RPS6KA3 (0.72) RPS6KA3DHODHESR1
SCHEMBL29101810 0.76 RAB9A (0.64) RAB9AKDM4ENPC1POLBGRIN2D
SCHEMBL8873768 0.75 GRIN2D (0.51) RAB9AKDM4ENPC1POLBGRIN2D
SCHEMBL8872788 0.73 KDM4E (0.53) RAB9AKDM4ENPC1DHODHPOLB
SCHEMBL8872656 0.73 KDM4E (0.53) RAB9AKDM4ENPC1DHODHGRIN2D
SCHEMBL8873477 0.73 KDM4E (0.53) RAB9AKDM4ENPC1GRIN2DGRIN3B
SCHEMBL2630604 0.73 RAB9A (0.74) RAB9AKDM4ENPC1POLBGRIN2D
SCHEMBL8872891 0.72 GRIN2D (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597922-A Glycine receptor antagonist pharmacophore STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) 1997-01-28 — — US disclosed
WO-1996004288-A1 GLYCINE RECEPTOR ANTAGONIST PHARMACOPHORE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1996-02-15 — — WO disclosed
Send feedback